Because Tim has no work to do at all but answer all emails. I would rather he was a scientist than a secretary. Your here to make money for your personal pleasure and gain. There's a man many years ago who had an idea to save lives and he's working at it.
Get over it. Probably 80% + of people in this share are down and so am I. If you don't have faith, leave . Tim was forced to talk, and he did and since nothing is concretely predictable in science history we all know. Now Tim shuts his damn mouth and does science while you vice versa.
This share may fail on me and I care about peoples lives BUT I am ONLY here to MAKE money.
YA have sold all the extra shares above the number for the equity swap - interesting. I'm surprised at how well the market has absorbed the 30m + shares sold. I don't now fear the gradual selling of the remainder over the next 12 months nearly as much as when the announcement was made.
I posted a link from the SFDA website on Monday which gives timescales. I doubt Tim will say anything over the phone (he knows the rules and might take the defensive aproach and say nothing) so maybe email him. It could be worded as a generic question and emailing would give him more time to consider a response, but let us know either way. Thanks
Good Morning.I am not that well versed in the chinese regulations regarding the clinical trials but you probably have given enough margin of error for this to be very realistic.I am going to phone TM and ask him directly about it.He should know.Stach
Hi Stach. Thanks. And if it takes 18 months then I guess I'll be around for a while.
But what I was referring to was that, by the end of the year, I would expect to hear that the pre-clinical work had been completed and that the lengthy SFDA process would start. That seems to take over 6 months alone prior to the authorisation to start the trials. The expectation is that phase 1 will start in Q1 2015 so with this lead time I expect to hear by September (to allow the 6 months).
You have done well for the new entrant here.Very good brief of what's to come.The only comment that I would differ with you is on the duration of FLT3/Aurora study results.There will be a minimum of 18 months before any conclusions can be drawn when it is used in treatment of an Acute Leukaemia with FLT-3 positivity.There maybe a first review at six month where very good results initially might be obtained and the RNS might come out to that effect but the length of Remission from leukaemia and the permanent negativity of stem cells from FLT-3 can not be ascertained in such a short period.I know this from my own practice as we have tried already FLT-3 Inhibitor in the UK( made by Cephalon of USA).Therfore a great deal of patience will be required from all of us here.The good thing is that it is the Chinese Institute who is financing the Study.You are right though that a greater number of patients maybe taking part in the Trial and therfore the statistics maybe more valuable in due course.ATB-Stach
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.